Sami Corwin
Stock Analyst at William Blair
(0.29)
# 4,492
Out of 4,496 analysts
5
Total ratings
n/a
Success rate
-8.65%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNYA Tenaya Therapeutics | Initiates: Outperform | n/a | $3.39 | - | 1 | Jun 10, 2024 | |
| NGNE Neurogene | Initiates: Outperform | n/a | $42.26 | - | 1 | Mar 21, 2024 | |
| MESO Mesoblast | Downgrades: Market Perform | n/a | $7.23 | - | 1 | Aug 4, 2023 | |
| CRSP CRISPR Therapeutics AG | Reinstates: Outperform | $75 | $54.56 | +37.46% | 1 | May 30, 2023 | |
| LEGN Legend Biotech | Initiates: Market Perform | n/a | $58.74 | - | 1 | May 25, 2023 |
Tenaya Therapeutics
Jun 10, 2024
Initiates: Outperform
Price Target: n/a
Current: $3.39
Upside: -
Neurogene
Mar 21, 2024
Initiates: Outperform
Price Target: n/a
Current: $42.26
Upside: -
Mesoblast
Aug 4, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.23
Upside: -
CRISPR Therapeutics AG
May 30, 2023
Reinstates: Outperform
Price Target: $75
Current: $54.56
Upside: +37.46%
Legend Biotech
May 25, 2023
Initiates: Market Perform
Price Target: n/a
Current: $58.74
Upside: -